Featured Research

from universities, journals, and other organizations

New, More Sensitive Nanotechnology Test For Chemical DNA Modifications Developed

Date:
September 24, 2008
Source:
American Association for Cancer Research
Summary:
Researchers have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.

Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.

During methylation, healthy genes can be switched on or off potentially causing cancer without any changes in the underlying DNA sequence. The current methods for methylation screening, have significant drawbacks, explains lead study author Vasudev Bailey, a biomedical engineering Ph.D. candidate at Hopkins.

Methylation specific PCR, which copies specific DNA sequences millions of times within a few hours, may not be sensitive enough to detect small amounts of methylation, and real time PCR, which allows scientists to view increases in the amount of DNA as it is copied, needs to be run several times and can be expensive, he says.

The Hopkins-developed test makes PCR technology more sensitive and efficient, Bailey said. The work was presented at the American Association for Cancer Research's third International Conference on Molecular Diagnostics in Cancer Therapeutic Development being held September 22-25, 2008, in Philadelphia.

"The impact of detecting DNA methylation is profound, as it has been demonstrated that a larger number of tumor suppressor genes become inactivated through DNA methylation than by mutations," Bailey said. "Our method of methylation screening provides an easy, cost-effective and valuable tool for the early diagnosis of cancer, monitoring tumor behavior and measuring the response of tumors to targeted cancer therapies."

To test the technique, Bailey and colleagues treated segments of DNA with the chemical compound sodium bisulfate. This automatically converted unmethylated cytosines (one of the bases of DNA) to uracils (one of the bases of ribonucleic acid or RNA, which works with DNA to synthesize proteins), while leaving the methylated cytosines untouched.

Then the scientists used PCR with labeled primers to copy and label these DNA segments with the vitamin biotin. Next, they added quantum dots (molecules about a billionth of a meter in size with electrical properties) to the samples that had been coated with the protein streptavidin. Like a magnetic force, the biotin-coated methylated segments of DNA were attracted to the streptavidin coating the quantum dots, highlighting and quantifying DNA methylation.

The new test was sensitive enough to detect as little as 15 picograms of methylated DNA in the presence of a 10,000-fold excess of unmethylated coding sequences, or the equivalent of five cells. In addition, they demonstrated detection capability in as few as eight PCR cycles. In collaboration with his colleague Yi Zhang, also a PhD candidate at Johns Hopkins school of medicine, they were able to see results using very small samples (an average of 800 billionth of a liter per reaction and more than fifty times less sample and reagent as used currently) using a novel lab-on-chip system. This system allows for minimal handing of samples from the researcher, while allowing for simultaneous processing and analysis of multiple samples. Researchers have a provisional patent on the test.

In additional experiments, the researchers used the technology to accurately detect methylation for the gene ASC/TMS1, which promotes programmed cell death, in low concentrations of DNA from human sputum. This was accomplished with fewer steps and fewer PCR cycles. Scientists also used the test to quantify the amount of methylation reversal in bone marrow fluid samples taken from patients with myelodysplastic syndrome – a disorder in which bone marrow cells don't function normally – before and after they had been treated with medications.

Bailey said the new test allows scientists to detect methylation of multiple genes at the same time, or view methylated and unmethylated DNA at the same time. It also reveals the percentage of methylation at any given time.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "New, More Sensitive Nanotechnology Test For Chemical DNA Modifications Developed." ScienceDaily. ScienceDaily, 24 September 2008. <www.sciencedaily.com/releases/2008/09/080923104303.htm>.
American Association for Cancer Research. (2008, September 24). New, More Sensitive Nanotechnology Test For Chemical DNA Modifications Developed. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2008/09/080923104303.htm
American Association for Cancer Research. "New, More Sensitive Nanotechnology Test For Chemical DNA Modifications Developed." ScienceDaily. www.sciencedaily.com/releases/2008/09/080923104303.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins